These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 10206464)
1. Neurofibromatosis-Noonan syndrome and acute lymphoblastic leukemia: a report of two cases. Klopfenstein KJ; Sommer A; Ruymann FB J Pediatr Hematol Oncol; 1999; 21(2):158-60. PubMed ID: 10206464 [TBL] [Abstract][Full Text] [Related]
2. Neurofibromatosis-Noonan Syndrome: A Possible Paradigm of the Combination of Genetic and Epigenetic Factors. Yapijakis C; Pachis N; Voumvourakis C Adv Exp Med Biol; 2017; 987():151-159. PubMed ID: 28971455 [TBL] [Abstract][Full Text] [Related]
3. Acute lymphoblastic leukemia in the context of RASopathies. Cavé H; Caye A; Strullu M; Aladjidi N; Vignal C; Ferster A; Méchinaud F; Domenech C; Pierri F; Contet A; Cacheux V; Irving J; Kratz C; Clavel J; Verloes A Eur J Med Genet; 2016 Mar; 59(3):173-8. PubMed ID: 26855057 [TBL] [Abstract][Full Text] [Related]
4. Exclusion of allelism of Noonan syndrome and neurofibromatosis-type 1 in a large family with Noonan syndrome-neurofibromatosis association. Bahuau M; Flintoff W; Assouline B; Lyonnet S; Le Merrer M; Prieur M; Guilloud-Bataille M; Feingold N; Munnich A; Vidaud M; Vidaud D Am J Med Genet; 1996 Dec; 66(3):347-55. PubMed ID: 8985499 [TBL] [Abstract][Full Text] [Related]
5. Mutations in RIT1 cause Noonan syndrome with possible juvenile myelomonocytic leukemia but are not involved in acute lymphoblastic leukemia. Cavé H; Caye A; Ghedira N; Capri Y; Pouvreau N; Fillot N; Trimouille A; Vignal C; Fenneteau O; Alembik Y; Alessandri JL; Blanchet P; Boute O; Bouvagnet P; David A; Dieux Coeslier A; Doray B; Dulac O; Drouin-Garraud V; Gérard M; Héron D; Isidor B; Lacombe D; Lyonnet S; Perrin L; Rio M; Roume J; Sauvion S; Toutain A; Vincent-Delorme C; Willems M; Baumann C; Verloes A Eur J Hum Genet; 2016 Aug; 24(8):1124-31. PubMed ID: 26757980 [TBL] [Abstract][Full Text] [Related]
6. Lethal presentation of neurofibromatosis and Noonan syndrome. Prada CE; Zarate YA; Hagenbuch S; Lovell A; Schorry EK; Hopkin RJ Am J Med Genet A; 2011 Jun; 155A(6):1360-6. PubMed ID: 21567923 [TBL] [Abstract][Full Text] [Related]
7. Is Neurofibromatosis Type 1-Noonan Syndrome a Phenotypic Result of Combined Genetic and Epigenetic Factors? Yapijakis C; Pachis N; Natsis S; Voumvourakis C In Vivo; 2016; 30(3):315-20. PubMed ID: 27107091 [TBL] [Abstract][Full Text] [Related]
8. Growth Hormone Deficiency in a Child with Neurofibromatosis-Noonan Syndrome. Vurallı D; Gönç N; Vidaud D; Özön A; Alikaşifoğlu A; Kandemir N J Clin Res Pediatr Endocrinol; 2016 Mar; 8(1):96-100. PubMed ID: 26758488 [TBL] [Abstract][Full Text] [Related]
9. Neurofibromatosis-Noonan syndrome: case report and clinicopathogenic review of the Neurofibromatosis-Noonan syndrome and RAS-MAPK pathway. Reig I; Boixeda P; Fleta B; Morenoc C; Gámez L; Truchuelo M Dermatol Online J; 2011 Apr; 17(4):4. PubMed ID: 21549079 [TBL] [Abstract][Full Text] [Related]
10. Different mutations in the NF1 gene are associated with Neurofibromatosis-Noonan syndrome (NFNS). Baralle D; Mattocks C; Kalidas K; Elmslie F; Whittaker J; Lees M; Ragge N; Patton MA; Winter RM; ffrench-Constant C Am J Med Genet A; 2003 May; 119A(1):1-8. PubMed ID: 12707950 [TBL] [Abstract][Full Text] [Related]
12. Acute lymphoblastic leukemia in Noonan syndrome: report of two cases. Piombo M; Rosanda C; Pasino M; Marasini M; Cerruti P; Comelli A Med Pediatr Oncol; 1993; 21(6):454-5. PubMed ID: 8515728 [TBL] [Abstract][Full Text] [Related]
13. Absence of linkage of Noonan syndrome to the neurofibromatosis type 1 locus. Sharland M; Taylor R; Patton MA; Jeffery S J Med Genet; 1992 Mar; 29(3):188-90. PubMed ID: 1348095 [TBL] [Abstract][Full Text] [Related]
14. Acute lymphoblastic leukemia developing in a patient with Noonan syndrome harboring a PTPN11 germline mutation. Sakamoto K; Imamura T; Asai D; Goto-Kawashima S; Yoshida H; Fujiki A; Furutani A; Ishida H; Aoki Y; Hosoi H J Pediatr Hematol Oncol; 2014 Mar; 36(2):e136-9. PubMed ID: 24072241 [TBL] [Abstract][Full Text] [Related]
15. Congenital absence of the superior oblique tendon in Noonan-neurofibromatosis syndrome. Sugumaran HK; Pappas JG; Kodsi SR J AAPOS; 2011 Dec; 15(6):593-4. PubMed ID: 22153407 [TBL] [Abstract][Full Text] [Related]
16. No evidence for linkage to the type 1 or type 2 neurofibromatosis loci in Noonan syndrome families. Flintoff WF; Bahuau M; Lyonnet S; Gilgenkrantz S; Lacombe D; Marçon F; Levilliers J; Kachaner J; Munnich A; Le Merrer M Am J Med Genet; 1993 Jul; 46(6):700-5. PubMed ID: 8362913 [TBL] [Abstract][Full Text] [Related]
17. Clinical variability of type 1 neurofibromatosis: is there a neurofibromatosis-Noonan syndrome? Stern HJ; Saal HM; Lee JS; Fain PR; Goldgar DE; Rosenbaum KN; Barker DF J Med Genet; 1992 Mar; 29(3):184-7. PubMed ID: 1348094 [TBL] [Abstract][Full Text] [Related]
18. Sporadic acute lymphocytic leukemia arising in a patient with neurofibromatosis and xanthogranulomatosis. Deb G; Habetswallner D; Helson L; De Sio L; Caniglia M; Donfrancesco A Cancer Invest; 1996; 14(2):109-11. PubMed ID: 8597895 [TBL] [Abstract][Full Text] [Related]
19. Neurofibromatosis/Noonan phenotype: a variable feature of type 1 neurofibromatosis. Colley A; Donnai D; Evans DG Clin Genet; 1996 Feb; 49(2):59-64. PubMed ID: 8740913 [TBL] [Abstract][Full Text] [Related]
20. Neurofibromatosis-Noonan syndrome and growth deficiency in an Iranian girl due to a pathogenic variant in NF1 gene. Dalili S; Hoseini Nouri SA; Bayat R; Koohmanaee S; Tabrizi M; Zarkesh M; Tarang A; Mahdieh N Hum Genomics; 2023 Feb; 17(1):12. PubMed ID: 36803953 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]